Before being read his rights, the suspect in the UnitedHealthcare CEO killing talked. Now his lawyers say those words could ...

Former Minnesota Vikings QB Fran Tarkenton said there is no substitute for making sure the right people are on your team — ...

Roblox CEO Dave Baszucki join e d The New York Times’ Hard Fork podcast to discuss the gaming platform’s new age-verification feature — but he seemed to get frustrated at the number of questions ...

The pharmaceutical company’s success developing medicines for obesity has swelled its worth to levels associated with tech titans like Apple and Google and dwarfed that of its drugmaking peers.

Aurobindo Pharma is doubling down on high-growth opportunities with a stronger injectables push, a streamlined capex approach, and a defined plan for expanding its Merck-CDMO operations, marking a ...

Shares of Merck & Company, Inc. (NASDAQ: MRK) are trading higher the FDA approved pembrolizumab with enfortumab vedotin-ejfv for muscle-invasive bladder cancer. MRK shares are powering higher on ...

Roblox CEO David Baszucki is taking heat for a recent podcast interview with the New York Times, in which he discussed the platform's new AI-powered age gating technology, dismissed accusations that ...

Nov 17 (Reuters) - Merck (MRK.N), opens new tab said on Monday it expects a commercial opportunity exceeding $5 billion from Cidara Therapeutics' (CDTX.O), opens new tab experimental flu drug, and ...

Nov 14 (Reuters) - Merck (MRK.N), opens new tab will acquire Cidara Therapeutics (CDTX.O), opens new tab in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its effort to ...

Merck MRK0.19%increase; green up pointing triangle & Co. has struck a $9.2 billion deal to buy biotechnology company Cidara Therapeutics CDTX 0.06%increase; green up pointing triangle in a move that ...

Merck & Co. is spending $9.2 billion for Cidara Therapeutics and its lead influenza antiviral that was dropped by Johnson & Johnson last year. Merck is paying $221.50 cash per share of Cidara, a San ...

(Reuters) -Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its effort to diversify ahead of patent loss for its blockbuster cancer ...